Literature DB >> 2858991

Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans.

J Swen, P J Gencarelli, H W Koot.   

Abstract

Steady-state infusion rate requirements of vecuronium were determined in 29 patients during either halothane-nitrous oxide or fentanyl-nitrous oxide anesthesia at different levels of neuromuscular block. During N2O-halothane anesthesia (end-tidal concentration, 0.5%), the infusion rate necessary for a steady-state (defined as unchanging twitch height and infusion rate for at least 20 min) 50% depression of twitch force was 28.8 +/- 5.4 (mean +/- SD) (n = 8) and 47.6 +/- 9.7 micrograms . kg-1 . hr-1 (n = 6) at 90% reduction of twitch force. During N2O-fentanyl anesthesia, the steady-state infusion rate required for 50 and 90% decrease of twitch force was 56.3 +/- 20.0 (n = 9) and 74.8 +/- 16.0 micrograms . kg-1 . hr-1 (n = 6), respectively. The variances of vecuronium steady-state infusion dose requirements were smaller in the halothane groups than in the fentanyl anesthesia groups. The steady-state vecuronium infusion dose requirements during fentanyl anesthesia were greater than the mean infusion dose requirements during halothane anesthesia at equivalent levels of twitch depression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858991

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  Continuous infusion of vecuronium in children.

Authors:  H Obara; H Hoshina; O Tanaka; R Chuma; H Kaetsu; N Maekawa; S Iwai
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

Review 2.  A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.

Authors:  R R Jaklitsch; D R Westenskow
Journal:  J Clin Monit       Date:  1990-01

Review 3.  Drug interactions with neuromuscular blockers.

Authors:  S Feldman; L Karalliedde
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

4.  A simple method for monitoring muscular relaxation during continuous infusion of vecuronium.

Authors:  H Nagashima; H D Nguyen; M Conforti; D Duncalf; P L Goldiner; F F Foldes
Journal:  Can J Anaesth       Date:  1988-03       Impact factor: 5.063

5.  Effect of low-dose infusion of prostaglandin E1 on vecuronium-induced neuromuscular blockade.

Authors:  Tatsuya Yamada; Reiko Yoshiyama; Yuki Iida; Shunichi Tachikawa; Koichi Tsuzaki
Journal:  J Anesth       Date:  1995-06       Impact factor: 2.078

Review 6.  Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

Review 7.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

8.  Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.

Authors:  W S Beattie; D N Buckley; J B Forrest
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.